Travere Therapeutics (TVTX) Long-Term Debt Issuances (2013 - 2022)
Travere Therapeutics' (TVTX) quarterly Long-Term Debt Issuances came in at $316.2 million in Q1 2022, up 14.79% on a QoQ basis from $275.5 million in Q3 2018.
Powered by 
Analysis
Travere Therapeutics (TVTX) Long-Term Debt Issuances (2013 - 2022) Analysis & Trends
Travere Therapeutics (TVTX) has 7 years of Long-Term Debt Issuances data on file, last reported at $316.2 million in Q1 2022.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to $316.2 million in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $316.2 million (changed N/A YoY) and the FY2022 annual result came in at $316.2 million, changed N/A from the prior year.
- Long-Term Debt Issuances improved to $316.2 million in Q1 2022, from $275.5 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $316.2 million in Q1 2022 to a low of $500000.0 in Q2 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Travere Therapeutics | 6.11 Bn | 6.11 Bn | 162.52 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 316.25 Mn |
| Sep 30, 2018 | 275.50 Mn |
| Jun 30, 2018 | 500,000.00 |
| Dec 31, 2017 | 102,000.00 |
| Sep 30, 2017 | 250,000.00 |
| Jun 30, 2017 | 250,000.00 |
| Mar 31, 2017 | 250,000.00 |
| Dec 31, 2016 | 250,000.00 |
| Sep 30, 2016 | 250,000.00 |
| Jun 30, 2016 | 500,000.00 |
| Dec 31, 2015 | 1.00 Mn |
| Sep 30, 2015 | 500,000.00 |
| Mar 31, 2015 | 500,000.00 |
| Sep 30, 2014 | 1.00 Mn |
| Dec 31, 2013 | 200,000.00 |